MedPath

Sugammadex doses for effective dose - reaction comparative study for the reversal of neuromuscular blockade induced by rocuronium.

Not Applicable
Conditions
Patients scheduled for elective surgery requiring general anesthesia
Registration Number
JPRN-UMIN000025218
Lead Sponsor
Department of Anesthesiology Nihon University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

the patients were ASA physical status 4-6 the patients who have renal or neuromuscular disorders the patients who are scheduled hepatic or renal surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The 95% effective dose of Sugammadex
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath